# Use of Myo-inositol as Adjuvant Therapy in Patients With Polycystic Ovary Syndrome (PCOS) in Vitro Fertilization (IVF)

> **NCT02221154** · PHASE4 · TERMINATED · sponsor: **Centre Hospitalier Departemental Vendee** · enrollment: 49 (actual)

## Conditions studied

- Polycystic Ovary Syndrome

## Interventions

- **DIETARY_SUPPLEMENT:** Inofolic®
- **OTHER:** Gonadotropins; Folic Acid

## Key facts

- **NCT ID:** NCT02221154
- **Lead sponsor:** Centre Hospitalier Departemental Vendee
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-11
- **Primary completion:** 2017-05-22
- **Final completion:** 2017-05-22
- **Target enrollment:** 49 (ACTUAL)
- **Why stopped:** Difficulty recruiting
- **Last updated:** 2017-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02221154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02221154, "Use of Myo-inositol as Adjuvant Therapy in Patients With Polycystic Ovary Syndrome (PCOS) in Vitro Fertilization (IVF)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02221154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*